Ed Perry

ED PERRY advises on a range of corporate matters, with a particular focus on private and public M&A transactions, and consortium and joint venture arrangements. This breadth of experience has enabled him to deliver strategically significant deals for clients across various different investment structures.

Ed works with a wide variety of clients, but has particular experience advising on transactions in highly regulated industries, such as the insurance and life sciences/healthcare sectors.

As in the previous edition (2023), Ed is recommended for M&A: Upper Mid-Market and Premium Deals by The Legal 500 UK 2024.

Ed joined Sidley in 2017 from a UK Magic Circle law firm, where he spent six years, including a six month secondment to the firm’s Paris office.

Ed’s recent experience includes advising:

• A global investment firm on its joint venture with a global sovereign investor to invest in, and secure the supply of, strategic metals and minerals.
• Arthur J. Gallagher & Co. in its agreement to acquire AssuredPartners for US$13.45 billion.
• Novo Holdings on its £50 million investment in Oxford Nanopore Technologies.
• HeadFirst Global on its recommended offer to acquire AIM-listed Impellam Group for approx. £483.2 million.
• Bank of Cyprus Holdings plc on its response to unsolicited takeover proposals submitted by an affiliate of a fund advised by Lone Star.
• Arthur J. Gallagher & Co., a global insurance brokerage, risk management and consulting services firm, in its acquisition of the treaty reinsurance brokerage operations of Willis Towers Watson for US$3.25 billion.
• PT Medco Energi Internasional Tbk on the takeover offer by a wholly owned subsidiary for Ophir Energy plc.
• Westfield Specialty in respect of its agreement, subject to receipt of applicable regulatory approvals and the satisfaction of certain other conditions, to purchase of Argo Underwriting Agency Limited and its subsidiaries (including their participation in and right to manage Lloyd's of London Syndicate 1200) from Argo Group for approximately $125 million.
• Crayhill Capital Management on the US$300 million financing for unybrands, an integrated platform for e-commerce businesses. 
• Arvelle Therapeutics, a Swiss-based biopharmaceutical company, on its sale to Angelini Pharma for a total cash consideration of up to US$960 million.
• KKR on the creation of a pan-European logistics development platform.
• The underwriters on the US$1 billion SEC-registered offering by Spanish issuer Banco Bilbao Vizcaya Argentaria.